China backs Roche's Actemra to fight coronavirus complicatio...

Chinese authorities have issued guidelines recommending Roche’s anti-inflammation drug Actemra to combat severe complications caused by the COVID-19 coronavirus.

CEOs give Trump 'Biology 101' lesson as coronavirus causes e...

There has been a political dimension to the coronavirus outbreak – there were the accusations of a cover-up by Chinese authorities around its epicentre in Wuhan – and in the

EU sets aside €45m for coronavirus drug and diagnostic R&D

Chinese biotech censured for misleading coronavirus drug cla...

China’s BrightGene Bio-Medical Technology has been censured by the Shanghai Stock Exchange for wrongly claiming it is able to manufacture Gilead’s experimental drug remdesivir – scientists’

Biogen and Sangamo work on Parkinson's and Alzheimer's gene ...

Biogen and Sangamo have begun a collaboration to develop gene regulation therapies for neurological diseases including Parkinson’s and Alzheimer’s in a collaboration worth more than $2.7 bi